{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:58:05Z","timestamp":1771340285350,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>West Nile Virus (WNV) is an emerging arthropod-born flavivirus with increasing distribution worldwide that is responsible for a large proportion of viral encephalitis in humans and horses. Given that there are no effective antiviral drugs available for treatment of the disease, efforts have been directed to develop vaccines to prevent WNV infection. Recently baculovirus has emerged as a novel and attractive gene delivery vehicle for mammalian cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the present study, recombinant baculoviruses expressing WNV premembrane (prM) and envelope (E) proteins under the cytomegalovirus (CMV) promoter with or without vesicular stomatitis virus glycoprotein (VSV\/G) were constructed. The recombinant baculoviruses designated Bac-G-prM\/E and Bac-prM\/E, efficiently express E protein in mammalian cells. Intramuscular injection of the two recombinant baculoviruses (at doses of 10<jats:sup>8<\/jats:sup> or 10<jats:sup>9<\/jats:sup> PFU\/mouse) induced the production of WNV-specific antibodies, neutralizing antibodies as well as gamma interferon (IFN-\u03b3) in a dose-dependent pattern. Interestingly, the recombinant baculovirus Bac-G-prM\/E was found to be a more efficient immunogen than Bac-prM\/E to elicit a robust immune response upon intramuscular injection. In addition, inoculation of baculovirus resulted in the secretion of inflammatory cytokines, such as TNF-\u03b1, IL-2 and IL-6.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These recombinant baculoviruses are capable of eliciting robust humoral and cellular immune responses in mice, and may be considered as novel vaccine candidates for West Nile Virus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-9-132","type":"journal-article","created":{"date-parts":[[2012,7,16]],"date-time":"2012-07-16T12:14:49Z","timestamp":1342440889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus"],"prefix":"10.1186","volume":"9","author":[{"given":"Bibo","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen F","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengbo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,16]]},"reference":[{"key":"1784_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3201\/eid0505.990505","volume":"5","author":"Z Hubalek","year":"1999","unstructured":"Hubalek Z, Halouzka J: West Nile fever\u2013a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis 1999, 5: 643-650. 10.3201\/eid0505.990505","journal-title":"Emerg Infect Dis"},{"key":"1784_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(02)00368-7","volume":"2","author":"GL Campbell","year":"2002","unstructured":"Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ: West Nile virus. Lancet Infect Dis 2002, 2: 519-529. 10.1016\/S1473-3099(02)00368-7","journal-title":"Lancet Infect Dis"},{"key":"1784_CR3","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1086\/521911","volume":"45","author":"DJ Gubler","year":"2007","unstructured":"Gubler DJ: The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007, 45: 1039-1046. 10.1086\/521911","journal-title":"Clin Infect Dis"},{"key":"1784_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3201\/eid0704.017421","volume":"7","author":"VL Kulasekera","year":"2001","unstructured":"Kulasekera VL, Kramer L, Nasci RS, Mostashari F, Cherry B, Trock SC, Glaser C, Miller JR: West Nile virus infection in mosquitoes, birds, horses, and humans, Staten Island, New York, 2000. Emerg Infect Dis 2001, 7: 722-725.","journal-title":"Emerg Infect Dis"},{"key":"1784_CR5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","volume":"344","author":"D Nash","year":"2001","unstructured":"Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, Rosenberg A, Greenberg A, Sherman M, et al.: The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001, 344: 1807-1814. 10.1056\/NEJM200106143442401","journal-title":"N Engl J Med"},{"key":"1784_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.antiviral.2009.05.006","volume":"83","author":"MS Diamond","year":"2009","unstructured":"Diamond MS: Progress on the development of therapeutics against West Nile virus. Antiviral Res 2009, 83: 214-227. 10.1016\/j.antiviral.2009.05.006","journal-title":"Antiviral Res"},{"key":"1784_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1051\/vetres\/2010039","volume":"41","author":"KO Murray","year":"2010","unstructured":"Murray KO, Mertens E, Despres P: West Nile virus and its emergence in the United States of America. Vet Res 2010, 41: 67. 10.1051\/vetres\/2010039","journal-title":"Vet Res"},{"key":"1784_CR8","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1128\/JVI.76.11.5480-5491.2002","volume":"76","author":"IC Lorenz","year":"2002","unstructured":"Lorenz IC, Allison SL, Heinz FX, Helenius A: Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol 2002, 76: 5480-5491. 10.1128\/JVI.76.11.5480-5491.2002","journal-title":"J Virol"},{"key":"1784_CR9","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1128\/JVI.00037-07","volume":"81","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Kaufmann B, Chipman PR, Kuhn RJ, Rossmann MG: Structure of immature West Nile virus. J Virol 2007, 81: 6141-6145. 10.1128\/JVI.00037-07","journal-title":"J Virol"},{"key":"1784_CR10","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1126\/science.1153263","volume":"319","author":"L Li","year":"2008","unstructured":"Li L, Lok SM, Yu IM, Zhang Y, Kuhn RJ, Chen J, Rossmann MG: The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 2008, 319: 1830-1834. 10.1126\/science.1153263","journal-title":"Science"},{"key":"1784_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.virol.2005.02.020","volume":"336","author":"MD Sanchez","year":"2005","unstructured":"Sanchez MD, Pierson TC, McAllister D, Hanna SL, Puffer BA, Valentine LE, Murtadha MM, Hoxie JA, Doms RW: Characterization of neutralizing antibodies to West Nile virus. Virology 2005, 336: 70-82. 10.1016\/j.virol.2005.02.020","journal-title":"Virology"},{"key":"1784_CR12","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1016\/j.vaccine.2006.12.005","volume":"25","author":"G Dauphin","year":"2007","unstructured":"Dauphin G, Zientara S: West Nile virus: recent trends in diagnosis and vaccine development. Vaccine 2007, 25: 5563-5576. 10.1016\/j.vaccine.2006.12.005","journal-title":"Vaccine"},{"key":"1784_CR13","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1016\/j.vaccine.2011.07.058","volume":"29","author":"T Ishikawa","year":"2011","unstructured":"Ishikawa T, Wang G, Widman DG, Infante E, Winkelmann ER, Bourne N, Mason PW: Enhancing the utility of a prM\/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene. Vaccine 2011, 29: 7444-7455. 10.1016\/j.vaccine.2011.07.058","journal-title":"Vaccine"},{"key":"1784_CR14","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1128\/JVI.80.8.4135-4146.2006","volume":"80","author":"C Kenoutis","year":"2006","unstructured":"Kenoutis C, Efrose RC, Swevers L, Lavdas AA, Gaitanou M, Matsas R, Iatrou K: Baculovirus-mediated gene delivery into Mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression. J Virol 2006, 80: 4135-4146. 10.1128\/JVI.80.8.4135-4146.2006","journal-title":"J Virol"},{"key":"1784_CR15","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1073\/pnas.93.6.2348","volume":"93","author":"FM Boyce","year":"1996","unstructured":"Boyce FM, Bucher NL: Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci U S A 1996, 93: 2348-2352. 10.1073\/pnas.93.6.2348","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1784_CR16","doi-asserted-by":"publisher","first-page":"14638","DOI":"10.1073\/pnas.260472897","volume":"97","author":"C Sarkis","year":"2000","unstructured":"Sarkis C, Serguera C, Petres S, Buchet D, Ridet JL, Edelman L, Mallet J: Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci U S A 2000, 97: 14638-14643. 10.1073\/pnas.260472897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1784_CR17","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1128\/JVI.77.18.9799-9808.2003","volume":"77","author":"H Tani","year":"2003","unstructured":"Tani H, Limn CK, Yap CC, Onishi M, Nozaki M, Nishimune Y, Okahashi N, Kitagawa Y, Watanabe R, Mochizuki R, et al.: In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 2003, 77: 9799-9808. 10.1128\/JVI.77.18.9799-9808.2003","journal-title":"J Virol"},{"key":"1784_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1745-7254.2005.00078.x","volume":"26","author":"YC Hu","year":"2005","unstructured":"Hu YC: Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 2005, 26: 405-416. 10.1111\/j.1745-7254.2005.00078.x","journal-title":"Acta Pharmacol Sin"},{"key":"1784_CR19","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1086\/425933","volume":"190","author":"M Qiao","year":"2004","unstructured":"Qiao M, Ashok M, Bernard KA, Palacios G, Zhou ZH, Lipkin WI, Liang TJ: Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells. J Infect Dis 2004, 190: 2104-2108. 10.1086\/425933","journal-title":"J Infect Dis"},{"key":"1784_CR20","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1089\/hum.1997.8.17-2011","volume":"8","author":"J Barsoum","year":"1997","unstructured":"Barsoum J, Brown R, McKee M, Boyce FM: Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 1997, 8: 2011-2018. 10.1089\/hum.1997.8.17-2011","journal-title":"Hum Gene Ther"},{"key":"1784_CR21","doi-asserted-by":"publisher","first-page":"8663","DOI":"10.1128\/JVI.78.16.8663-8672.2004","volume":"78","author":"A Facciabene","year":"2004","unstructured":"Facciabene A, Aurisicchio L, La Monica N: Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 2004, 78: 8663-8672. 10.1128\/JVI.78.16.8663-8672.2004","journal-title":"J Virol"},{"key":"1784_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1073\/pnas.96.1.127","volume":"96","author":"JP Condreay","year":"1999","unstructured":"Condreay JP, Witherspoon SM, Clay WC, Kost TA: Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci U S A 1999, 96: 127-132. 10.1073\/pnas.96.1.127","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1784_CR23","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1128\/JVI.79.5.2847-2858.2005","volume":"79","author":"T Abe","year":"2005","unstructured":"Abe T, Hemmi H, Miyamoto H, Moriishi K, Tamura S, Takaku H, Akira S, Matsuura Y: Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 2005, 79: 2847-2858. 10.1128\/JVI.79.5.2847-2858.2005","journal-title":"J Virol"},{"key":"1784_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/156652310791321279","volume":"10","author":"T Abe","year":"2010","unstructured":"Abe T, Matsuura Y: Host innate immune responses induced by baculovirus in mammals. Curr Gene Ther 2010, 10: 226-231. 10.2174\/156652310791321279","journal-title":"Curr Gene Ther"},{"key":"1784_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0378-1135(99)00110-8","volume":"68","author":"H Aoki","year":"1999","unstructured":"Aoki H, Sakoda Y, Jukuroki K, Takada A, Kida H, Fukusho A: Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet Microbiol 1999, 68: 197-207. 10.1016\/S0378-1135(99)00110-8","journal-title":"Vet Microbiol"},{"key":"1784_CR26","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.1016\/j.vaccine.2007.09.069","volume":"25","author":"S Wang","year":"2007","unstructured":"Wang S, Fang L, Fan H, Jiang Y, Pan Y, Luo R, Zhao Q, Chen H, Xiao S: Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 2007, 25: 8220-8227. 10.1016\/j.vaccine.2007.09.069","journal-title":"Vaccine"},{"key":"1784_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jviromet.2008.02.011","volume":"150","author":"H Fan","year":"2008","unstructured":"Fan H, Pan Y, Fang L, Wang D, Wang S, Jiang Y, Chen H, Xiao S: Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J Virol Methods 2008, 150: 21-26. 10.1016\/j.jviromet.2008.02.011","journal-title":"J Virol Methods"},{"key":"1784_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00705-010-0909-4","volume":"156","author":"H Huang","year":"2011","unstructured":"Huang H, Xiao S, Qin J, Jiang Y, Yang S, Li T, Gao Y, Li Z, Su X, Ruan Y, et al.: Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice. Arch Virol 2011, 156: 753-758. 10.1007\/s00705-010-0909-4","journal-title":"Arch Virol"},{"key":"1784_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jgm.1271","volume":"11","author":"Y Li","year":"2009","unstructured":"Li Y, Ye J, Cao S, Xiao S, Zhao Q, Liu X, Jin M, Chen H: Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. J Gene Med 2009, 11: 57-65. 10.1002\/jgm.1271","journal-title":"J Gene Med"},{"key":"1784_CR30","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1073\/pnas.022652799","volume":"99","author":"AG Pletnev","year":"2002","unstructured":"Pletnev AG, Putnak R, Speicher J, Wagar EJ, Vaughn DW: West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc Natl Acad Sci U S A 2002, 99: 3036-3041. 10.1073\/pnas.022652799","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1784_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1086\/426824","volume":"191","author":"P Despres","year":"2005","unstructured":"Despres P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F: Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis 2005, 191: 207-214. 10.1086\/426824","journal-title":"J Infect Dis"},{"key":"1784_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jgm.837","volume":"8","author":"MC Iglesias","year":"2006","unstructured":"Iglesias MC, Frenkiel MP, Mollier K, Souque P, Despres P, Charneau P: A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus. J Gene Med 2006, 8: 265-274. 10.1002\/jgm.837","journal-title":"J Gene Med"},{"key":"1784_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.vaccine.2008.11.087","volume":"27","author":"AV Iyer","year":"2009","unstructured":"Iyer AV, Pahar B, Boudreaux MJ, Wakamatsu N, Roy AF, Chouljenko VN, Baghian A, Apetrei C, Marx PA, Kousoulas KG: Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01. Vaccine 2009, 27: 893-903. 10.1016\/j.vaccine.2008.11.087","journal-title":"Vaccine"},{"key":"1784_CR34","doi-asserted-by":"publisher","first-page":"e18995","DOI":"10.1371\/journal.pone.0018995","volume":"6","author":"BEE Martina","year":"2011","unstructured":"Martina BEE, van den Doel P, Koraka P, van Amerongen G, Spohn G, Haagmans BL, Provacia LBV, Osterhaus ADME, Rimmelzwaan GF: A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus. PLoS One 2011, 6: e18995. 10.1371\/journal.pone.0018995","journal-title":"PLoS One"},{"key":"1784_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","volume":"4","author":"TC Pierson","year":"2008","unstructured":"Pierson TC, Fremont DH, Kuhn RJ, Diamond MS: Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 2008, 4: 229-238. 10.1016\/j.chom.2008.08.004","journal-title":"Cell Host Microbe"},{"key":"1784_CR36","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1128\/JVI.00286-09","volume":"83","author":"MR Vogt","year":"2009","unstructured":"Vogt MR, Moesker B, Goudsmit J, Jongeneelen M, Austin SK, Oliphant T, Nelson S, Pierson TC, Wilschut J, Throsby M, Diamond MS: Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J Virol 2009, 83: 6494-6507. 10.1128\/JVI.00286-09","journal-title":"J Virol"},{"key":"1784_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1056\/NEJM198809083191004","volume":"319","author":"CH Hoke","year":"1988","unstructured":"Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S, Gingrich JB, Latendresse J, Fukai K, et al.: Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988, 319: 608-614. 10.1056\/NEJM198809083191004","journal-title":"N Engl J Med"},{"key":"1784_CR38","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1016\/j.vaccine.2011.04.116","volume":"29","author":"A Schneeweiss","year":"2011","unstructured":"Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, B\u00fcrki K, Liebert UG, Ulbert S: A DNA vaccine encoding the E protein of West Nile Virus is protective and can be boosted by recombinant domain DIII. Vaccine 2011, 29: 6352-6357. 10.1016\/j.vaccine.2011.04.116","journal-title":"Vaccine"},{"key":"1784_CR39","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","volume":"78","author":"B Shrestha","year":"2004","unstructured":"Shrestha B, Diamond MS: Role of CD8+ T cells in control of West Nile virus infection. J Virol 2004, 78: 8312-8321. 10.1128\/JVI.78.15.8312-8321.2004","journal-title":"J Virol"},{"key":"1784_CR40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.4049\/jimmunol.181.2.1563","volume":"181","author":"R Parsons","year":"2008","unstructured":"Parsons R, Lelic A, Hayes L, Carter A, Marshall L, Evelegh C, Drebot M, Andonova M, McMurtrey C, Hildebrand W, et al.: The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes. J Immunol 2008, 181: 1563-1572.","journal-title":"J Immunol"},{"key":"1784_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","volume":"26","author":"BE Martina","year":"2008","unstructured":"Martina BE, Koraka P, van den Doel P, van Amerongen G, Rimmelzwaan GF, Osterhaus AD: Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine 2008, 26: 153-157. 10.1016\/j.vaccine.2007.10.055","journal-title":"Vaccine"},{"key":"1784_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1369-5274(98)80058-1","volume":"1","author":"MJ Estcourt","year":"1998","unstructured":"Estcourt MJ, Ramshaw A, Ramsay AJ: Cytokine responses in virus infections: effects on pathogenesis, recovery and persistence. Curr Opin Microbiol 1998, 1: 411-418. 10.1016\/S1369-5274(98)80058-1","journal-title":"Curr Opin Microbiol"},{"key":"1784_CR43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1086\/317537","volume":"32","author":"B Spellberg","year":"2001","unstructured":"Spellberg B, Edwards JE: Type 1\/Type 2 immunity in infectious diseases. Clin Infect Dis 2001, 32: 76-102. 10.1086\/317537","journal-title":"Clin Infect Dis"},{"key":"1784_CR44","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4049\/jimmunol.171.3.1133","volume":"171","author":"T Abe","year":"2003","unstructured":"Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, Takaku H: Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 2003, 171: 1133-1139.","journal-title":"J Immunol"},{"key":"1784_CR45","doi-asserted-by":"publisher","first-page":"10548","DOI":"10.1128\/JVI.01250-09","volume":"83","author":"GY Chen","year":"2009","unstructured":"Chen GY, Shiah HC, Su HJ, Chen CY, Chuang YJ, Lo WH, Huang JL, Chuang CK, Hwang SM, Hu YC: Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 pathway. J Virol 2009, 83: 10548-10556. 10.1128\/JVI.01250-09","journal-title":"J Virol"},{"key":"1784_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jviromet.2008.09.019","volume":"154","author":"J Liu","year":"2008","unstructured":"Liu J, Liu B, Cao Z, Inoue S, Morita K, Tian K, Zhu Q, Gao GF: Characterization and application of monoclonal antibodies specific to West Nile virus envelope protein. J Virol Methods 2008, 154: 20-26. 10.1016\/j.jviromet.2008.09.019","journal-title":"J Virol Methods"},{"key":"1784_CR47","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1016\/j.vaccine.2009.07.078","volume":"27","author":"Y Li","year":"2009","unstructured":"Li Y, Xu M, Chen L, Zhu J, Ye J, Liu X, Sun Y, Chen H, Cao S: Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus. Vaccine 2009, 27: 6004-6010. 10.1016\/j.vaccine.2009.07.078","journal-title":"Vaccine"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-9-132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:40:58Z","timestamp":1630525258000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-9-132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,16]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1784"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-9-132","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,16]]},"assertion":[{"value":"21 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"132"}}